Christopher D. Sarsons
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 3
-
- Platelet Disorders and Treatments 1
- Co-authors
- Kristina D. Rinker (8 shared papers)David T. Cramb (6 shared papers)Jonathan V. Rocheleau (1 shared paper)David M. Hwang (1 shared paper)Qin Dai (1 shared paper)Edward A. Sykes (1 shared paper)Juan Chen (1 shared paper)Gang Zheng (1 shared paper)
- Journals
- RSC Advances (2 papers)Biomedicines (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Biomedicine & Pharmacotherapy (1 paper)Journal of Biomedical Nanotechnology (1 paper)
- Partner nations
- CanadaEgyptUnited States
In The Last Decade
Christopher D. Sarsons
13 papers receiving 523 citations
Peers
Comparison fields: 5 of 79
- Biomaterials 200
- Pharmaceutical Science 27
- Biomedical Engineering 178
- Molecular Biology 235
- Nephrology 18
Countries citing papers authored by Christopher D. Sarsons
This map shows the geographic impact of Christopher D. Sarsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Sarsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Sarsons more than expected).
Fields of papers citing papers by Christopher D. Sarsons
This network shows the impact of papers produced by Christopher D. Sarsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Sarsons. The network helps show where Christopher D. Sarsons may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher D. Sarsons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 249 | |
| 2 | 2019 | 104 | |
| 3 | 2018 | 53 | |
| 4 | 2018 | 48 | |
| 5 | 2016 | 23 | |
| 6 | 2018 | 18 | |
| 7 | 2016 | 11 | |
| 8 | 2022 | 10 | |
| 9 | 2012 | 8 | |
| 10 | 2023 | 7 | |
| 11 | 2014 | 5 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 2 | |
| 14 | RELATING QUANTUM DOT ASSOCIATION WITH HUMAN ENDOTHELIAL CELLS WITH THEIR CYTOTOXIC EFFECTS | 2015 | 1 |
About Christopher D. Sarsons
Christopher D. Sarsons is a scholar working on Biomaterials, Hematology, Molecular Biology, Electronic, Optical and Magnetic Materials and Oncology, having authored 14 papers that have together received 543 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Gold and Silver Nanoparticles Synthesis and Applications (2 papers), Peptidase Inhibition and Analysis (1 paper), Catalytic C–H Functionalization Methods (1 paper), Pregnancy and preeclampsia studies (1 paper), CAR-T cell therapy research (1 paper) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Biomaterials (200 citations), Pharmaceutical Science (27 citations), Biomedical Engineering (178 citations), Molecular Biology (235 citations) and Nephrology (18 citations). Christopher D. Sarsons has collaborated with scholars based in Canada, Egypt and United States. Frequent co-authors include Kristina D. Rinker, David T. Cramb, Jonathan V. Rocheleau, David M. Hwang, Qin Dai, Edward A. Sykes, Juan Chen, Gang Zheng, Warren C. W. Chan and Michael Sweeney. Their work appears in journals such as RSC Advances, Biomedicines, Nanomedicine Nanotechnology Biology and Medicine, Biomedicine & Pharmacotherapy and Journal of Biomedical Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.